Correlation Between Tarsus Pharmaceuticals and Tyra Biosciences
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Tyra Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Tyra Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Tyra Biosciences, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Tyra Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Tyra Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Tyra Biosciences.
Diversification Opportunities for Tarsus Pharmaceuticals and Tyra Biosciences
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Tarsus and Tyra is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Tyra Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tyra Biosciences and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Tyra Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tyra Biosciences has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Tyra Biosciences go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Tyra Biosciences
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.76 times more return on investment than Tyra Biosciences. However, Tarsus Pharmaceuticals is 1.32 times less risky than Tyra Biosciences. It trades about 0.21 of its potential returns per unit of risk. Tyra Biosciences is currently generating about -0.06 per unit of risk. If you would invest 2,617 in Tarsus Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 2,557 from holding Tarsus Pharmaceuticals or generate 97.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Tyra Biosciences
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Tyra Biosciences |
Tarsus Pharmaceuticals and Tyra Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Tyra Biosciences
The main advantage of trading using opposite Tarsus Pharmaceuticals and Tyra Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Tyra Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tyra Biosciences will offset losses from the drop in Tyra Biosciences' long position.| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
| Tyra Biosciences vs. Connect Biopharma Holdings | Tyra Biosciences vs. RAPT Therapeutics | Tyra Biosciences vs. Xilio Development | Tyra Biosciences vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |